Manitoba Nephrology Nurse Practice Test

When managing pain in patients with chronic kidney disease, it is essential to consider the patient's renal function and the nephrotoxic potential of analgesics. Chronic kidney disease (CKD) affects how the body metabolizes and excretes medications, including pain relief medications. Many analgesics can be harmful to the kidneys, particularly non-steroidal anti-inflammatory drugs (NSAIDs) and certain opioids, which may require dosage adjustments or avoidance altogether depending on the patient's level of kidney function.

In patients with impaired renal function, the risks of accumulating medications or their metabolites increase, potentially leading to toxicity or exacerbated kidney damage. Therefore, careful evaluation of renal function, often through glomerular filtration rate (GFR) assessments, is crucial for determining safe and effective pain management strategies. This highlights the importance of a tailored approach that prioritizes both symptom relief and the preservation of kidney health.